AGP Executive Report
Last update: 6 hours agoRegenerative Medicine Push: Sarawak plans a RM50M Sarawak Regenerative BioFoundry to build an end-to-end cell and gene therapy ecosystem, linking manufacturing, clinical work, research, and wellness. Mental Health & Cannabis: A new psychiatry discussion argues cannabis-associated psychosis may be biologically distinct from schizophrenia, raising public-health questions as use grows. PBM Transparency Models: PBMI Innovators highlight managed-care pharmacy careers and why some PBMs are moving toward full pass-through pricing amid pressure for clearer rebate practices. Primary Care Access: Ghana’s President Mahama launches Free Primary Healthcare in Bolgatanga East with home visits to screen for hypertension, diabetes, and maternal/newborn risks. Drug Pricing Crossfire: Coverage examines how 340B discounts can overlap with IRA Medicare negotiation rules, complicating manufacturer obligations. AI at FDA: Experts weigh AI’s efficiency gains in FDA review against oversight and confidentiality concerns. Urology Evidence: Tranexamic acid shows reduced major bleeding in urologic surgery without clear added thrombotic risk. Interoperability Update: Epic rolls out one-click diagnostic image exchange so outside hospitals can share scans without CDs. Cancer Care Advance: BMS wins first approval for CELMoD iberdomide (Zenbexus) in multiple myeloma.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
